King Levoxyl NDA Approval Anticipated In May Ahead of FDA August Deadline
Executive Summary
King expects FDA to approve its Levoxyl NDA by the end of May, the company's President and Chief Operating Officer Jeff Gregory said during a conference call Feb. 20.